Chargement en cours...
Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
The most commonly used oral drug in treating type 2 diabetes (T2DM) after metformin are sufonylureas (SUs) based on the confidence gained over the several decades and because of its cheaper cost. Unfortunately, SUs are associated with secondary failure and sometimes associated with therapy related s...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4171882/ https://ncbi.nlm.nih.gov/pubmed/25285276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.139214 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|